Elon Musk's Neuralink Blindsight: Restoring Sight to the Blind by 2026

• Neuralink's "Blindsight" brain implant aims to restore vision to blind individuals, with first human tests planned for 2026.
• The technology connects directly to the brain's visual cortex, potentially benefiting those with damaged eyes/optic nerves and even people blind from birth.
• Blindsight received Breakthrough Device designation from the U.S. FDA in September 2024, indicating its potential for serious conditions.
• Successful tests on monkeys were announced in March 2025, showing the implant's functionality.
• Initial vision quality may be low, but future capabilities could include infrared, UV, and radar-like sight, potentially surpassing normal human vision.

Why It Matters: Neuralink's Blindsight offers hope for the blind, aiming for human trials by 2026 with revolutionary vision capabilities.